{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:15Z","timestamp":1787008635275,"version":"build-2736575974"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:00:00Z","timestamp":1549065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS054805"],"award-info":[{"award-number":["NS054805"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS086968)"],"award-info":[{"award-number":["NS086968)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EF033-235\u20132015)"],"award-info":[{"award-number":["EF033-235\u20132015)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW001140"],"award-info":[{"award-number":["D43TW001140"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW007393)"],"award-info":[{"award-number":["D43TW007393)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The efficacy of albendazole therapy in patients with parenchymal neurocysticercosis (NCC) is suboptimal. Plasma levels of albendazole sulfoxide (ASOX), the active metabolite of albendazole, are highly variable among patients. We hypothesized that high ASOX plasma levels during albendazole therapy may be associated with an increased antiparasitic efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ASOX plasma levels were measured at treatment day 7 in 118 patients with parenchymal NCC enrolled in a treatment trial. The relationships between increasing ASOX plasma levels with the proportion of cysts resolved and the proportion of patients with complete cyst resolution (evaluated by 6-month brain magnetic resonance) were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was a trend toward a higher proportion of cysts resolved and a higher proportion of patients cured with increasing quartiles of ASOX plasma levels. In patients with 3 or more brain cysts, the regression analysis adjusted by the concomitant administration of praziquantel (PZQ) showed a 2-fold increase in the proportion of cysts resolved (risk ratio [RR], 1.98; 95% confidence interval [CI], 1.01\u20133.89; P = .048) and 2.5-fold increase in the proportion of patients cured (RR, 2.45; 95% CI, .94\u20136.36; P = .067) when ASOX levels in the highest vs the lowest quartile were compared. No association was found in patients with 1\u20132 brain cysts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We suggest an association between high ASOX plasma levels and increased antiparasitic efficacy in patients with parenchymal NCC. Nonetheless, this association is also influenced by other factors including parasite burden and concomitant administration of PZQ. These findings may serve to individualize and\/or adjust therapy schemes to avoid treatment failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciz085","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T15:14:47Z","timestamp":1548429287000},"page":"1996-2002","source":"Crossref","is-referenced-by-count":19,"title":["Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis"],"prefix":"10.1093","volume":"69","author":[{"given":"Gianfranco","family":"Arroyo","sequence":"first","affiliation":[{"name":"School of Public Health and Administration, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A","family":"Bustos","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Sciences, Lima"},{"name":"Center for Global Health, Universidad Peruana Cayetano Heredia, Lima"},{"name":"Cysticercosis Unit, Instituto Nacional de Ciencias Neurol\u00f3gicas, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres G","family":"Lescano","sequence":"additional","affiliation":[{"name":"School of Public Health and Administration, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Gonzales","sequence":"additional","affiliation":[{"name":"Cysticercosis Unit, Instituto Nacional de Ciencias Neurol\u00f3gicas, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Saavedra","sequence":"additional","affiliation":[{"name":"Cysticercosis Unit, Instituto Nacional de Ciencias Neurol\u00f3gicas, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Cysticercosis Unit, Instituto Nacional de Ciencias Neurol\u00f3gicas, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Javier","family":"Pretell","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Alberto Sabogal, Callao, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierina S","family":"Bonato","sequence":"additional","affiliation":[{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera L","family":"Lanchote","sequence":"additional","affiliation":[{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo M","family":"Takayanagui","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo Brasil, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horton","sequence":"additional","affiliation":[{"name":"Tropical Projects, Hitchin, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando E","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H","family":"Gilman","sequence":"additional","affiliation":[{"name":"Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector H","family":"Garcia","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Sciences, Lima"},{"name":"Center for Global Health, Universidad Peruana Cayetano Heredia, Lima"},{"name":"Cysticercosis Unit, Instituto Nacional de Ciencias Neurol\u00f3gicas, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cysticercosis Working Group in Peru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor C W","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"O\u2019Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Zimic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Verastegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Mayta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesenia","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T","family":"Lopez-Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar M","family":"Gavidia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A","family":"Gomez-Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz M","family":"Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddartha","family":"Mahanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukwan","family":"Handali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,2]]},"reference":[{"key":"2019111315181553500_CIT0001","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia","year":"2014","journal-title":"Lancet Neurol"},{"key":"2019111315181553500_CIT0002","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1371\/journal.pntd.0001500","article-title":"Neurocysticercosis: neglected but not forgotten","volume":"6","author":"Coyle","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2019111315181553500_CIT0003","doi-asserted-by":"crossref","first-page":"e0005153","DOI":"10.1371\/journal.pntd.0005153","article-title":"Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy","volume":"11","author":"Debacq","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2019111315181553500_CIT0004","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(05)70194-0","article-title":"Neurocysticercosis: updated concepts about an old disease","volume":"4","author":"Garcia","year":"2005","journal-title":"Lancet Neurol"},{"key":"2019111315181553500_CIT0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1708-8305.2011.00583.x","article-title":"Neurocysticercosis in immigrant populations","volume":"19","author":"Garcia","year":"2012","journal-title":"J Travel Med"},{"key":"2019111315181553500_CIT0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vetpar.2011.07.017","article-title":"The socioeconomic burden of parasitic zoonoses: global trends","volume":"182","author":"Torgerson","year":"2011","journal-title":"Vet Parasitol"},{"key":"2019111315181553500_CIT0007","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3201\/eid2106.141324","article-title":"Hospitalization frequency and charges for neurocysticercosis, United States, 2003\u20132012","volume":"21","author":"O\u2019Neal","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2019111315181553500_CIT0008","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actatropica.2016.01.017","article-title":"Estimation of the health and economic burden of neurocysticercosis in India","volume":"165","author":"Singh","year":"2017","journal-title":"Acta Trop"},{"key":"2019111315181553500_CIT0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00314663","article-title":"Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis","volume":"237","author":"Sotelo","year":"1990","journal-title":"J Neurol"},{"key":"2019111315181553500_CIT0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0035-9203(93)90095-8","article-title":"Short course albendazole treatment for neurocysticercosis in Columbia","volume":"87","author":"Botero","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019111315181553500_CIT0011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111315181553500_CIT0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yebeh.2017.03.013","article-title":"Antiparasitic treatment of neurocysticercosis\u2014the effect of cyst destruction in seizure evolution","volume":"76","author":"Garcia","year":"2017","journal-title":"Epilepsy Behav"},{"key":"2019111315181553500_CIT0013","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0169-4758(88)90192-5","article-title":"The anthelmintic action of praziquantel","volume":"4","author":"Harnett","year":"1988","journal-title":"Parasitol Today"},{"key":"2019111315181553500_CIT0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/41.2.145","article-title":"Albendazole","volume":"41","author":"Venkatesan","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"2019111315181553500_CIT0015","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.pntd.0000194","article-title":"Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials","volume":"2","author":"Matthaiou","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"2019111315181553500_CIT0016","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00003088-199834060-00006","article-title":"Pharmacokinetic optimisation of the treatment of neurocysticercosis","volume":"34","author":"Sotelo","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"2019111315181553500_CIT0017","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2125.2002.01634.x","article-title":"Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis","volume":"54","author":"Takayanagui","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"2019111315181553500_CIT0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/ecp.11.72","article-title":"Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis","volume":"5","author":"Jung-Cook","year":"2012","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2019111315181553500_CIT0019","first-page":"679","article-title":"Population pharmacokinetics of albendazole in patients with neurocysticercosis","volume":"47","author":"Castro","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2019111315181553500_CIT0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.2011.03945.x","article-title":"Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis","volume":"72","author":"Garcia","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2019111315181553500_CIT0021","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(14)70779-0","article-title":"Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial","volume":"14","author":"Garcia","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2019111315181553500_CIT0022","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/cid\/ciw134","article-title":"Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis","volume":"62","author":"Garcia","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019111315181553500_CIT0023","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jpba.2006.11.020","article-title":"Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry","volume":"44","author":"Bonato","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"2019111315181553500_CIT0024","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2019111315181553500_CIT0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7326\/0003-4819-145-1-200607040-00009","article-title":"Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel","volume":"145","author":"Del Brutto","year":"2006","journal-title":"Ann Intern Med"},{"key":"2019111315181553500_CIT0026","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bmc.1659","article-title":"A simple LC-MS\/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis","volume":"26","author":"Gonz\u00e1lez-Hern\u00e1ndez","year":"2012","journal-title":"Biomed Chromatogr"},{"key":"2019111315181553500_CIT0027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/bdd.327","article-title":"Dose dependent pharmacokinetics of albendazole in human","volume":"23","author":"Mirfazaelian","year":"2002","journal-title":"Biopharm Drug Dispos"},{"key":"2019111315181553500_CIT0028","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.wnl.0000195887.63124.dc","article-title":"Albendazole trial at 15 or 30 mg\/kg\/day for subarachnoid and intraventricular cysticercosis","volume":"66","author":"G\u00f6ngora-Rivera","year":"2006","journal-title":"Neurology"},{"key":"2019111315181553500_CIT0029","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/00034983.1994.11812903","article-title":"Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men","volume":"88","author":"Homeida","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"key":"2019111315181553500_CIT0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2125.2010.03874.x","article-title":"Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity","volume":"71","author":"Lima","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2019111315181553500_CIT0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"2019111315181553500_CIT0032","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1471-4159.2003.02081.x","article-title":"P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins","volume":"87","author":"Jodoin","year":"2003","journal-title":"J Neurochem"},{"key":"2019111315181553500_CIT0033","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2006.05.009","article-title":"The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux","volume":"29","author":"Hayeshi","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"2019111315181553500_CIT0034","doi-asserted-by":"crossref","first-page":"e0140147","DOI":"10.1371\/journal.pone.0140147","article-title":"The role of efflux pumps in Schistosoma mansoni praziquantel resistant phenotype","volume":"10","author":"Pinto-Almeida","year":"2015","journal-title":"PLoS One"},{"key":"2019111315181553500_CIT0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2125.2004.02096.x","article-title":"Drug metabolism and ageing","volume":"57","author":"Kinirons","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"2019111315181553500_CIT0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin Liver Dis"},{"key":"2019111315181553500_CIT0037","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00228-002-0488-8","article-title":"Effect of gender in the disposition of albendazole metabolites in humans","volume":"58","author":"Mirfazaelian","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"2019111315181553500_CIT0038","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2125.2000.00170.x","article-title":"Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes","volume":"49","author":"Rawden","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"2019111315181553500_CIT0039","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord"},{"key":"2019111315181553500_CIT0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00007691-200206000-00003","article-title":"Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis","volume":"24","author":"Lanchote","year":"2002","journal-title":"Ther Drug Monit"},{"key":"2019111315181553500_CIT0041","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007691-199702000-00009","article-title":"Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone","volume":"19","author":"Takayanagui","year":"1997","journal-title":"Ther Drug Monit"},{"key":"2019111315181553500_CIT0042","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40262-015-0243-9","article-title":"A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole","volume":"54","author":"Pawluk","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"2019111315181553500_CIT0043","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4269\/ajtmh.1998.59.832","article-title":"Time-response curve of oxfendazole in the treatment of swine cysticercosis","volume":"59","author":"Gonzalez","year":"1998","journal-title":"Am J Trop Med Hyg"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz085\/28545092\/ciz085.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/11\/1996\/30678551\/ciz085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/11\/1996\/30678551\/ciz085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T01:54:00Z","timestamp":1606182840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/11\/1996\/5306011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,2]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,2,2]]},"published-print":{"date-parts":[[2019,11,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz085","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12,1]]},"published":{"date-parts":[[2019,2,2]]}}}